147 related articles for article (PubMed ID: 34786859)
21. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
He W; Turkeshi A; Li X; Zhang H
Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
[TBL] [Abstract][Full Text] [Related]
22. Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.
Fan R; Xiao C; Wan X; Cha W; Miao Y; Zhou Y; Qin C; Cui T; Su F; Shan X
RNA Biol; 2019 Jun; 16(6):707-718. PubMed ID: 30900502
[TBL] [Abstract][Full Text] [Related]
23. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
[TBL] [Abstract][Full Text] [Related]
24. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.
Zhang P; Chen H; Liu J; Liu G
Methods Mol Biol; 2019; 2054():283-294. PubMed ID: 31482462
[TBL] [Abstract][Full Text] [Related]
25. Lipid Nanoparticles to Deliver miRNA in Cancer.
Campani V; De Rosa G; Misso G; Zarone MR; Grimaldi A
Curr Pharm Biotechnol; 2016; 17(8):741-9. PubMed ID: 27215371
[TBL] [Abstract][Full Text] [Related]
26. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery.
Tagalakis AD; Maeshima R; Yu-Wai-Man C; Meng J; Syed F; Wu LP; Aldossary AM; McCarthy D; Moghimi SM; Hart SL
Acta Biomater; 2017 Mar; 51():351-362. PubMed ID: 28110069
[TBL] [Abstract][Full Text] [Related]
27. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
28. Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy.
Del Pozo-Acebo L; Hazas MLL; Tomé-Carneiro J; Gil-Cabrerizo P; San-Cristobal R; Busto R; García-Ruiz A; Dávalos A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499350
[TBL] [Abstract][Full Text] [Related]
29. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
[TBL] [Abstract][Full Text] [Related]
30. Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics.
Kim OY; Dinh NT; Park HT; Choi SJ; Hong K; Gho YS
Biomaterials; 2017 Jan; 113():68-79. PubMed ID: 27810643
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.
Di Ianni T; Bose RJC; Sukumar UK; Bachawal S; Wang H; Telichko A; Herickhoff C; Robinson E; Baker S; Vilches-Moure JG; Felt SA; Gambhir SS; Paulmurugan R; Dahl JD
J Control Release; 2019 Sep; 309():1-10. PubMed ID: 31326463
[TBL] [Abstract][Full Text] [Related]
32. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
33. Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma.
Pottoo FH; Barkat MA; Harshita ; Ansari MA; Javed MN; Sajid Jamal QM; Kamal MA
Semin Cancer Biol; 2021 Feb; 69():100-108. PubMed ID: 31562954
[TBL] [Abstract][Full Text] [Related]
34. A Multiscale Model to Identify Limiting Factors in Nanoparticle-Based miRNA Delivery for Tumor Inhibition
Dogra P; Ramirez JR; Butner JD; Pelaez MJ; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4230-4233. PubMed ID: 34892157
[TBL] [Abstract][Full Text] [Related]
35. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy.
Wang YQ; Ji MY; Wang C
Int J Pharm; 2020 May; 582():119331. PubMed ID: 32289484
[TBL] [Abstract][Full Text] [Related]
36. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
[TBL] [Abstract][Full Text] [Related]
38. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates.
Xu L; Wang Y; Zhu C; Ren S; Shao Y; Wu L; Li W; Jia X; Hu R; Chen R; Chen Z
Theranostics; 2020; 10(18):8162-8178. PubMed ID: 32724464
[No Abstract] [Full Text] [Related]
39. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
40. Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Joshi N; Shirsath N; Singh A; Joshi KS; Banerjee R
Sci Rep; 2014 Nov; 4():7085. PubMed ID: 25403950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
